首页> 外文期刊>Transplant international : >De Novo Membranoproliferative Glomerulonephritis III in a renal transplant patient: Case report and review of the literature
【24h】

De Novo Membranoproliferative Glomerulonephritis III in a renal transplant patient: Case report and review of the literature

机译:De Novo肾移植患者发生膜增生性肾小球性肾炎III:病例报告和文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

Idiopathic membranoproliferative glomerulonephritis (MPGN) is a rare cause of renal failure with a cumulative incidence of 0.3% of all ESRD and 4% of all primary glomerulonephritis for types I and II. Membranoproliferative glomerulonephritis type III is more uncommon and idiopathic de novo MPGN III in a renal transplant patient has not been reported. We present the case of a 57-year old white female patient with a diagnosis of lithium toxicity as cause of end stage renal disease (ESRD) who developed MPGN III in her allograft 6 years after a renal transplant. Despite treatment, she progressed to ESRD within four and a half years from the time of diagnosis.
机译:特发性膜增生性肾小球肾炎(MPGN)是一种罕见的肾衰竭原因,对于I型和II型,累加发生率占所有ESRD的0.3%和所有原发性肾小球性肾炎的4%。 III型膜增生性肾小球肾炎较为罕见,尚未有肾移植患者特发性新生MPGN III的报道。我们介绍了一位57岁的白人女性患者,该患者被诊断为锂毒性,是终末期肾脏疾病(ESRD)的原因,该患者在肾脏移植6年后的同种异体移植中发展了MPGN III。尽管进行了治疗,但在诊断后的四年半内她仍发展为ESRD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号